Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug...
Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced that the Company presented new preclinical data demonstrating the...
